Mergers & acquisitions PMO assessment: multinational biopharmaceuticals provider

Multinational biopharmaceuticals provider

September 8, 2020

Challenge:

Client was experiencing integration challenges and wanted to evaluate their M&A PMO processes.

Existing challenges included:

  • Limited engagement from IT and other functional teams on merger and acquisition projects
  • No formal M&A plans place to own the requirements gathering, design, development, and implementation of network and telecommunications, virtual and physical infrastructure, core infrastructure services, security and support services, or messaging and collaboration
  • Very aggressive timeline with limited engagement and communication beyond corporate development team

How Mazars helped:

We assembled a team of skilled M&A and business process improvement professionals experienced in assessing PMOs.

Solution:

  • Provided robust assessment based on Merger Integration and Project Management Institute (PMI) best practices
  • Interviewed internal and external stakeholders and vendors to identify process gaps and opportunities to increase integration engagement and efficiency
  • Shared leverageable tools, templates and processes to develop a strategic approach to merger integration activity

Result:

  • Successfully delivered M&A assessment and framework based on people, process, and technology success factors
  • Implemented an IT PMO strategic engagement model that:
    • Increased engagement, efficiency and communications in current and future integrations
    • Delivered improved success and value to future acquisition integrations